上市公司的第二大股东——杭州华东医药集团有限公司，为杭州市人民政府授权

上市公司的第二大股东——杭州华东医药集团有限公司，为杭州市人民政府授权经营企业，属于国有独资企业，持有上市公司16.46%股权，不拥有控股权。不参与上市公司的实际运营，仅通过其派出董事参与上市公司董事会重大决策。

結果 (英文) 1:

The second-largest shareholder of listed companies-Hangzhou East China pharmaceutical group limited, for Hangzhou City people's Government trading enterprises, belonging to state-owned enterprises, listed 16.46% shares of the company, does not have a controlling interest. Do not participate in the actual operations of listed companies, only through its major decisions of the Board of directors were sent listed companies.

結果 (英文) 2:

The second largest shareholder of listed companies - Hangzhou East China Pharmaceutical Group Co., Ltd., Hangzhou People's Government authorized enterprises, belonging to state-owned enterprises, listed companies held 16.46% stake, does not own a controlling stake. Not involved in the actual operations of listed companies, only through their participation in the board of directors of listed companies to send major decisions.

結果 (英文) 3:

Listed companies of the second largest shareholder -- Hangzhou Huadong Medicine Group Co., Ltd., Hangzhou Municipal People's government authorization business, belonging to state-owned enterprises, holding public 16.46% stake in the company and does not own a controlling stake. Does not participate in the actual operation of the listing Corporation, only through its board of directors to participate in major decisions of the board of directors of the listing Corporation.